49 related articles for article (PubMed ID: 2330490)
1. Treatment of coccidioidal meningitis with fluconazole.
Tucker RM; Galgiani JN; Denning DW; Hanson LH; Graybill JR; Sharkey K; Eckman MR; Salemi C; Libke R; Klein RA
Rev Infect Dis; 1990; 12 Suppl 3():S380-9. PubMed ID: 2330490
[TBL] [Abstract][Full Text] [Related]
2. Coccidioidal meningitis complicated by central nervous system vasculitis in a patient with leukemia.
Tager D; Hatch A; Segar J; Roller B; Al Mohajer M; Zangeneh TT
Med Mycol Case Rep; 2017 Jun; 16():8-11. PubMed ID: 28386527
[TBL] [Abstract][Full Text] [Related]
3. Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.
Krogstad P; Johnson R; Garcia-Lloret MI; Heidari A; Butte MJ
Clin Ther; 2019 Oct; 41(10):1939-1954.e1. PubMed ID: 31648806
[TBL] [Abstract][Full Text] [Related]
4. Central Nervous System Infections Due to Coccidioidomycosis.
Jackson NR; Blair JE; Ampel NM
J Fungi (Basel); 2019 Jun; 5(3):. PubMed ID: 31261704
[TBL] [Abstract][Full Text] [Related]
5. THE TREATMENT OF COCCIDIOIDOMYCOSIS.
Ampel NM
Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):51-6. PubMed ID: 26465370
[TBL] [Abstract][Full Text] [Related]
6. Antifungal clinical trials and guidelines: what we know and do not know.
Pappas PG
Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a019745. PubMed ID: 25368017
[TBL] [Abstract][Full Text] [Related]
7. Reflections on the approach to treatment of a mycologic disaster.
Stevens DA
Antimicrob Agents Chemother; 2013 Apr; 57(4):1567-72. PubMed ID: 23384533
[No Abstract] [Full Text] [Related]
8. Safety of fluconazole in paediatrics: a systematic review.
Egunsola O; Adefurin A; Fakis A; Jacqz-Aigrain E; Choonara I; Sammons H
Eur J Clin Pharmacol; 2013 Jun; 69(6):1211-21. PubMed ID: 23325436
[TBL] [Abstract][Full Text] [Related]
9. Coccidioidal meningitis: update on epidemiology, clinical features, diagnosis, and management.
Blair JE
Curr Infect Dis Rep; 2009 Jul; 11(4):289-95. PubMed ID: 19545498
[TBL] [Abstract][Full Text] [Related]
10. Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis.
Kamberi P; Sobel RA; Clemons KV; Waldvogel A; Striebel JM; Williams PL; Stevens DA
Antimicrob Agents Chemother; 2007 Mar; 51(3):998-1003. PubMed ID: 17178793
[TBL] [Abstract][Full Text] [Related]
11. Central Nervous System Coccidioides immitis Infections.
Davis LE; Porter BS
Curr Treat Options Neurol; 2005 Mar; 7(2):157-165. PubMed ID: 15676119
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.
Clemons KV; Sobel RA; Williams PL; Pappagianis D; Stevens DA
Antimicrob Agents Chemother; 2002 Aug; 46(8):2420-6. PubMed ID: 12121913
[TBL] [Abstract][Full Text] [Related]
13. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.
González GM; Tijerina R; Najvar LK; Bocanegra R; Luther M; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 2001 Jun; 45(6):1854-9. PubMed ID: 11353637
[TBL] [Abstract][Full Text] [Related]
14. Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.
Chapman SW; Rogers PD; Rinaldi MG; Sullivan DC
Antimicrob Agents Chemother; 1998 Apr; 42(4):978-80. PubMed ID: 9559827
[TBL] [Abstract][Full Text] [Related]
15. Drug treatment of HIV-related opportunistic infections.
Klepser ME; Klepser TB
Drugs; 1997 Jan; 53(1):40-73. PubMed ID: 9010648
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis.
Yang H; Wang Q; Elmquist WF
Pharm Res; 1996 Oct; 13(10):1570-5. PubMed ID: 8899853
[TBL] [Abstract][Full Text] [Related]
17. Coccidioidomycosis.
Galgiani JN
West J Med; 1993 Aug; 159(2):153-71. PubMed ID: 8212681
[TBL] [Abstract][Full Text] [Related]
18. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Clemons KV; Homola ME; Stevens DA
Antimicrob Agents Chemother; 1995 May; 39(5):1169-72. PubMed ID: 7625808
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions to systemic antifungals. Prevention and management.
Perfect JR; Lindsay MH; Drew RH
Drug Saf; 1992; 7(5):323-63. PubMed ID: 1418692
[TBL] [Abstract][Full Text] [Related]
20. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
Lyman CA; Walsh TJ
Drugs; 1992 Jul; 44(1):9-35. PubMed ID: 1379913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
